Filtrer vos résultats
- 2
- 1
- 2
- 1
- 3
- 1
- 1
- 1
- 3
- 3
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
Effectiveness of second-line treatment in AL amyloidosis patient's refractory to M-Dex.Amyloid: The Journal of Protein Folding Disorders, 2011, 18 Suppl 1, pp.145-7. ⟨10.3109/13506129.2011.574354054⟩
Article dans une revue
hal-00945683v1
|
|||
Autologus stern celle transplantation (ASCT) versus oral melphalan and high-dose dexamethasone in patients with AL (primary) amyloisdosis : results of the French multicentric randomized trial (MAG and IFM intergroup).Communication orale présentée à 'The American Society of Hematology 47th Annual meeting and Exposition", Dec 2005, Nouvelle Orléans (Louisiane), United States
Communication dans un congrès
hal-01135622v1
|
|||
|
Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disordersKidney International, 2019, 96 (1), pp.94-103. ⟨10.1016/j.kint.2019.01.027⟩
Article dans une revue
hal-02132592v1
|